FibRestoration - Novel specialized probiotics for restoring a healthy fiber-degrading microbiome
The project aims to develop probiotics containing cellulose-degrading bacteria to enhance gut microbiome fiber degradation and improve human health, addressing a gap in current probiotic offerings.
Projectdetails
Introduction
Dietary fiber is well-recognized as beneficial to the gut microbiome and has repercussions on human health. Consequently, in recent years, alternative dietary lifestyles favoring the consumption of high amounts of dietary fibers have been proposed.
Problem Statement
In order to avoid digestive discomfort associated with the increased intake of dietary fiber, we propose to develop probiotics that will target cellulose, the main component of dietary fiber. Indeed, cellulose-degrading bacteria are absent both in the gut microbiomes of most human populations and in existing probiotics.
Project Objectives
During our proposed project, we will:
- Isolate unique fiber-degrading bacteria.
- Restore these bacteria in the human microbiome via the administration of probiotics.
Product Development
Thus, our products will comprise this bacterium either alone or in combination with other fiber-degrading strains. This will augment the fiber-degrading potential of the human gut microbiome with concomitant implications for human health.
Market Potential
Such probiotics will address the majority of global human populations and will constitute a niche in the global probiotics market, which is projected to further increase in the next decade.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 150.000 |
Totale projectbegroting | € 150.000 |
Tijdlijn
Startdatum | 1-1-2023 |
Einddatum | 30-6-2025 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- BEN-GURION UNIVERSITY OF THE NEGEVpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Exploring functional inter-individual variations in the intestinal microbiome for personalized nutritionThe InterBiome project aims to explore how dietary components affect individual microbiota variations, influencing health outcomes and paving the way for personalized medicine and dietary strategies. | ERC Consolid... | € 2.000.000 | 2025 | Details |
SYNergize: Understanding spore-forming gut bacteria biology to target pathogensSYNergize aims to characterize gut spore-formers to develop synbiotics that inhibit pathogens and combat antimicrobial resistance through enhanced understanding of sporulation and transmission processes. | ERC Starting... | € 1.499.503 | 2024 | Details |
Microbial Synthetic in vivo Cell Therapy SystemsThe MiStiC project aims to develop Clostridium leptum as a stable chassis for localized drug production and delivery, targeting colorectal cancer through engineered biosensors and natural product pathways. | ERC Starting... | € 1.499.938 | 2023 | Details |
Proteome-wide Functional Interrogation and Modulation of Gut Microbiome SpeciesThis project aims to identify and manipulate gut microbiome protein functions using high-throughput proteomics to develop targeted therapies for restoring microbial health. | ERC Starting... | € 1.499.980 | 2023 | Details |
Nanostructure formation during food protein digestion and influence on intestinal transportPRODIGEST aims to enhance sustainable food production by investigating the structural and mechanistic aspects of protein digestion to improve nutrient bioavailability and health outcomes. | ERC Consolid... | € 2.355.741 | 2023 | Details |
Exploring functional inter-individual variations in the intestinal microbiome for personalized nutrition
The InterBiome project aims to explore how dietary components affect individual microbiota variations, influencing health outcomes and paving the way for personalized medicine and dietary strategies.
SYNergize: Understanding spore-forming gut bacteria biology to target pathogens
SYNergize aims to characterize gut spore-formers to develop synbiotics that inhibit pathogens and combat antimicrobial resistance through enhanced understanding of sporulation and transmission processes.
Microbial Synthetic in vivo Cell Therapy Systems
The MiStiC project aims to develop Clostridium leptum as a stable chassis for localized drug production and delivery, targeting colorectal cancer through engineered biosensors and natural product pathways.
Proteome-wide Functional Interrogation and Modulation of Gut Microbiome Species
This project aims to identify and manipulate gut microbiome protein functions using high-throughput proteomics to develop targeted therapies for restoring microbial health.
Nanostructure formation during food protein digestion and influence on intestinal transport
PRODIGEST aims to enhance sustainable food production by investigating the structural and mechanistic aspects of protein digestion to improve nutrient bioavailability and health outcomes.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Precision nutrition approach for increasing fibre intake and health using microbiota-matched sustainable fibre sourcesFIBRE-MATCH aims to personalize dietary fiber types to gut microbiome subtypes for improved metabolic outcomes and gastrointestinal health in individuals, particularly those with IBS. | EIC Pathfinder | € 3.449.447 | 2024 | Details |
FERTI-LILY Probiotic GelRosesta Medical ontwikkelt innovatieve probiotische behandelingen om het vaginale microbioom te stabiliseren en de conceptiekansen te verhogen, met focus op de Lactobacillus crispatus bacterie. | Mkb-innovati... | € 20.000 | 2020 | Details |
Ontwikkeling van duurzame gezonde texturisersHet project 'Next' ontwikkelt een milde extractietechnologie voor het verbeteren van natuurlijke vezels, gericht op het creëren van nieuwe vezeltypes en het bevorderen van duurzaamheid en gezondheid. | Mkb-innovati... | € 110.250 | 2015 | Details |
INTELLIGENT ENCAPSULATION AND SCREENING PLATFORM FOR PRECISION DELIVERY OF PROBIOTICS TO IMPROVE GUT HEALTHiNSIGHT aims to develop precision probiotics through innovative microencapsulation for targeted delivery, enhancing gut health and addressing related diseases using advanced technology and personalized treatment. | EIC Pathfinder | € 3.194.343 | 2025 | Details |
Ontwikkeling van liposomen met FOS, SCFA, PUFALiposoma Health ontwikkelt liposomale nutraceuticals met fructo-oligosacchariden en vetzuren om de gezondheid van mensen met een afwijkend microbioom te verbeteren, met focus op Parkinson, depressie en diabetes. | Mkb-innovati... | € 20.000 | 2020 | Details |
Precision nutrition approach for increasing fibre intake and health using microbiota-matched sustainable fibre sources
FIBRE-MATCH aims to personalize dietary fiber types to gut microbiome subtypes for improved metabolic outcomes and gastrointestinal health in individuals, particularly those with IBS.
FERTI-LILY Probiotic Gel
Rosesta Medical ontwikkelt innovatieve probiotische behandelingen om het vaginale microbioom te stabiliseren en de conceptiekansen te verhogen, met focus op de Lactobacillus crispatus bacterie.
Ontwikkeling van duurzame gezonde texturisers
Het project 'Next' ontwikkelt een milde extractietechnologie voor het verbeteren van natuurlijke vezels, gericht op het creëren van nieuwe vezeltypes en het bevorderen van duurzaamheid en gezondheid.
INTELLIGENT ENCAPSULATION AND SCREENING PLATFORM FOR PRECISION DELIVERY OF PROBIOTICS TO IMPROVE GUT HEALTH
iNSIGHT aims to develop precision probiotics through innovative microencapsulation for targeted delivery, enhancing gut health and addressing related diseases using advanced technology and personalized treatment.
Ontwikkeling van liposomen met FOS, SCFA, PUFA
Liposoma Health ontwikkelt liposomale nutraceuticals met fructo-oligosacchariden en vetzuren om de gezondheid van mensen met een afwijkend microbioom te verbeteren, met focus op Parkinson, depressie en diabetes.